China Shineway Pharmaceutical Group Limited (C1S) — Strategic Asset Allocation Index
China Shineway Pharmaceutical Group Limited (C1S) has a Strategic Asset Allocation Index of 18.7% as of June 2023. Strategic assets (PP&E of €1.24 Billion plus long-term investments of €-) total €1.24 Billion, measured against net assets of €6.64 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
China Shineway Pharmaceutical Group Limited Strategic Asset Allocation Index (2013–2022)
This chart shows how China Shineway Pharmaceutical Group Limited's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 18.7%, representing strategic assets of €1.24 Billion against net assets of €6.64 Billion EUR. Explore China Shineway Pharmaceutical Group Limi operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for China Shineway Pharmaceutical Group Limited (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for China Shineway Pharmaceutical Group Limited from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see China Shineway Pharmaceutical Group Limi (C1S) total market value.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 19.1% | €1.22 Billion | €1.22 Billion | €- | €6.38 Billion | ▼ -2.1 pp |
| 2021 | 21.2% | €1.25 Billion | €1.25 Billion | €- | €5.90 Billion | ▼ -2.9 pp |
| 2020 | 24.1% | €1.39 Billion | €1.39 Billion | €- | €5.79 Billion | ▼ -1.8 pp |
| 2019 | 25.9% | €1.49 Billion | €1.49 Billion | €- | €5.78 Billion | ▲ +1.5 pp |
| 2018 | 24.3% | €1.40 Billion | €1.40 Billion | €- | €5.77 Billion | ▲ +0.3 pp |
| 2017 | 24.1% | €1.40 Billion | €1.40 Billion | €- | €5.82 Billion | ▼ -2.0 pp |
| 2016 | 26.1% | €1.47 Billion | €1.47 Billion | €- | €5.63 Billion | ▼ -2.8 pp |
| 2015 | 28.9% | €1.53 Billion | €1.53 Billion | €- | €5.30 Billion | ▼ -3.3 pp |
| 2014 | 32.2% | €1.57 Billion | €1.57 Billion | €- | €4.89 Billion | ▼ -3.9 pp |
| 2013 | 36.1% | €1.60 Billion | €1.60 Billion | €- | €4.43 Billion | — |